Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1,783,229
-
Shares change
-
-156,246
-
Total reported value, excl. options
-
$29,172,000
-
Value change
-
-$2,661,400
-
Number of buys
-
13
-
Number of sells
-
-9
-
Price
-
$16.36
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2021
22 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q4 2021.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,783,229 shares
.
Largest 10 shareholders include INVESTMENT MANAGEMENT OF VIRGINIA LLC (615,554 shares), Roumell Asset Management, LLC (495,684 shares), VILLERE ST DENIS J & CO LLC (256,872 shares), ARK Investment Management LLC (165,454 shares), BROWN ADVISORY INC (61,350 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (58,694 shares), Zurcher Kantonalbank (Zurich Cantonalbank) (24,623 shares), Weil Company, Inc. (21,210 shares), Kingsview Wealth Management, LLC (18,415 shares), and LPL Financial LLC (14,770 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.